Partnerships

Vendor Login

Success from Synergy

Successful partnerships are the result of a synergistic relationship between two groups with the same vision. At Norgenix Pharmaceuticals, we believe in synergistic partnerships.

Norgenix Pharmaceuticals, a wholly owned subsidiary of JM Smith Corporation (one of the largest privately held healthcare companies in the United States with four corporate divisions and one wholly owned subsidiary):

• Norgenix Pharmaceuticals, an innovative pharmaceutical company that commercializes and markets novel pharmaceutical products and devices.
• Smith Drug, One of the top 10 wholesale drug companies in the U.S.
• QS/1, a provider of pharmacy hardware and software systems.
• Smith Premier Services, assists customers with pharmacy insurance claims, adjudication, compliance and disease management.
• Integral Solutions, an internet technology and communications company.

Partnerships to Fulfill Unmet Needs

Norgenix Pharmaceuticals is dedicated to in-licensing product opportunities and building strategic alliances with companies interested in maximizing the value of products that fulfill unmet medical needs in the U.S. marketplace.

As a strategic partner, Norgenix and the related JM Smith partner companies will provide strategic direction and capitalization to build success.

Unparalleled Expertise

Norgenix has the resources to market products quickly, efficiently, and effectively. The Norgenix senior management team has more than 150 years of combined healthcare experience launching products in both the U.S. and global markets. Their experience in pharmaceutical sales has been nationally recognized and Norgenix business insights are well regarded by leading U.S. pharmaceutical, biotechnology, and medical device companies.

Innovation that Accelerates Sales

Norgenix has an innovative business model and capabilities proven to accelerate market entrance for novel products, including the following:'

Accelerating Market Success

• Capitalization
• Established infrastructure
• Nationwide wholesale distribution network
• More than 150 years of combined experience
• Commitment to synergistic alliances

Aligning the Partnership

Norgenix is seeking to collaborate with U.S. companies that have:

• Products in late stage development
• Products pending approval (NDA,ANDA,505b2, and OTC)
• Novel medical device technology
• Existing market-ready products

Norgenix is also seeking to established strategic alliances with global companies interested in commercializing products in the U.S. These companies benefit from and established infrastructure, which can expedite market entrance.

If you are considering a collaborative partnership with an experienced company dedicated to the same goals, please contact us.